Quest Diagnostics Inc

Quest Diagnostics insider sale by EVP Catherine Doherty: routine tax‑planning moves amid steady growth, no price impact, and a continued confidence signal for shareholders.

Executive equity moves at Quest Diagnostics reveal disciplined RSU handling, high‑level shareholder confidence, and market‑positive signals for investors and clinicians alike.

Insightful guide on how Patrick Plewman’s discounted insider purchase signals confidence in Quest Diagnostics, plus key trends shaping the diagnostics industry.